{"schema_version":"secwatch.filing_event.v1","accession":"0000950159-23-000272","form_type":"8-K","ticker":"CI","cik":"0001739940","company_name":"Cigna Group","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.275313+00:00","generated_at":"2026-06-09T00:40:48.513636+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cigna Q3 adj EPS $6.77, revenue $49.0B; raises FY2023 adj EPS outlook to at least $24.75","bullets":["Q3 shareholders' net income $1.4B ($4.74/share) vs $2.8B ($8.97) a year ago; adjusted income from ops $2.0B ($6.77/share) up 8% YoY.","Total revenues $49.0B, up 8% YoY; adjusted revenues $49.1B; Evernorth adj rev $38.6B (+8%), Cigna Healthcare adj rev $12.8B (+14%).","FY2023 outlook raised: adjusted EPS at least $24.75 (from at least $24.70), revenue at least $192B (from $190B), cash from ops at least $10.5B (from $9.5B).","Medical customers 19.6M, up 9% vs Dec 2022; YTD share repurchases 7.7M shares for ~$2.2B; debt-to-cap 40.5% vs 41.9% at June 30."],"urls":{"canonical":"https://secwatch.observer/filing/0000950159-23-000272","json":"https://secwatch.observer/filing/0000950159-23-000272.json","markdown":"https://secwatch.observer/filing/0000950159-23-000272.md","text":"https://secwatch.observer/filing/0000950159-23-000272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739940/000095015923000272/0000950159-23-000272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739940/000095015923000272/cigna8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:40:48.513636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ade2651167961b0ee8b31107497c14ca1b3020fd","claim":"Cigna Group reported the three months ended September 30, 2023 results: revenue $49,048, net income $1,408, EPS $4.74 per share. Guidance raised.","evidence_excerpt":"1 : Consolidated Financial Results (dollars in millions): Three Months Ended Nine Months Ended September 30, June 30, September 30, 2023 2022 3 2023 2023 Total Revenues $ 49,048 $ 45,281 $ 48,586 $ 144,151 Net Realized Investment Losses from Equity Method Investments 5 30 80 30 22 Adjusted Revenues 5 $ 49,078 $ 45,361 $ 48,616 $ 144,173 Consolidated","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739940/000095015923000272/0000950159-23-000272-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended September 30, 2023"},{"label":"Revenue","value":"$49,048"},{"label":"Net income","value":"$1,408"},{"label":"EPS","value":"$4.74 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}